Literature DB >> 21808941

The ADMIT series--Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique.

Mariëlle E A C Broeders1, Walter Vincken, Lorenzo Corbetta.   

Abstract

Since inhalation therapy will probably remain the preferred route of treatment for patients with chronic obstructive pulmonary disease (COPD), it is important to provide helpful information that may assist physicians and nurses in selecting the appropriate device(s) for individual patients as well as prescribing the correct medication. In line with the GOLD guidelines, the Aerosol Drug Management Improvement Team (ADMIT) propose a three-part "therapy adjustment strategy", which provides health care professionals with a way to monitor and check the delivery of inhaled medication. The strategy is a summation of the key principles behind the evidence-based management of stable COPD and exacerbations. It offers physicians a rapid and user-friendly overview of the requirements of COPD management starting with making the diagnosis and continuing with optimisation of therapy in follow-up appointments. It includes everything from check lists for disease assessment and recommendations for reducing risk factors to selecting the proper inhalers and continuous checking of compliance and correct inhaler technique. These practical COPD therapy adjustment algorithms have been used as part of an interactive online course developed by the ADMIT group (www.admit-online.info). The COPD "flash" video available at this web site offers suggestions on how to organise a complete doctor-patient consultation.

Entities:  

Mesh:

Year:  2011        PMID: 21808941      PMCID: PMC6549856          DOI: 10.4104/pcrj.2011.00062

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  14 in total

Review 1.  Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.

Authors:  Christopher M Blanchette; Nicholas J Gross; Pablo Altman
Journal:  Am Health Drug Benefits       Date:  2014-04

2.  Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

Authors:  Sergi Pascual; Jan Feimer; Anthony De Soyza; Jaume Sauleda Roig; John Haughney; Laura Padullés; Beatriz Seoane; Ludmyla Rekeda; Anna Ribera; Henry Chrystyn
Journal:  NPJ Prim Care Respir Med       Date:  2015-04-30       Impact factor: 2.871

3.  Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting β₂-agonists: a dispensing database analysis.

Authors:  Job F M van Boven; Joost J van Raaij; Ruben van der Galiën; Maarten J Postma; Thys van der Molen; P N Richard Dekhuijzen; Stefan Vegter
Journal:  NPJ Prim Care Respir Med       Date:  2014-10-02       Impact factor: 2.871

4.  Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial.

Authors:  José Leiva-Fernández; Rubén L Vázquez-Alarcón; Virginia Aguiar-Leiva; Mireya Lobnig-Becerra; Francisca Leiva-Fernández; Pilar Barnestein-Fonseca
Journal:  Trials       Date:  2016-03-17       Impact factor: 2.279

5.  The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.

Authors:  Sinthia Bosnic-Anticevich; Henry Chrystyn; Richard W Costello; Myrna B Dolovich; Monica J Fletcher; Federico Lavorini; Roberto Rodríguez-Roisin; Dermot Ryan; Simon Wan Yau Ming; David B Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-21

6.  Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.

Authors:  Daiki Hira; Hiroyoshi Koide; Shigemi Nakamura; Toyoko Okada; Kazunori Ishizeki; Masafumi Yamaguchi; Setsuko Koshiyama; Tetsuya Oguma; Kayoko Ito; Saori Funayama; Yuko Komase; Shin-Ya Morita; Kohshi Nishiguchi; Yasutaka Nakano; Tomohiro Terada
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

7.  Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of Breezhaler and Respimat.

Authors:  Philip O'Hagan; Juergen Dederichs; Boomi Viswanad; Matthias Gasser; Susann Walda
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 8.  Considerations for managing chronic obstructive pulmonary disease in the elderly.

Authors:  George E Taffet; James F Donohue; Pablo R Altman
Journal:  Clin Interv Aging       Date:  2013-12-13       Impact factor: 4.458

9.  Study protocol for a randomized, controlled trial comparing the efficacy of two educational interventions to improve inhalation techniques in patients with chronic obstructive pulmonary disease (COPD): TIEPOC Study.

Authors:  José Leiva-Fernández; Francisca Leiva-Fernández; Rubén L Vázquez-Alarcón; Antonio García-Ruiz; Daniel Prados-Torres; Pilar Barnestein-Fonseca
Journal:  Drugs Context       Date:  2014-04-24

10.  Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.

Authors:  Veronika Müller; Gabriella Gálffy; Márta Orosz; Zsuzsanna Kováts; Balázs Odler; Olof Selroos; Lilla Tamási
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.